Intra-articular administration of an antibody against CSF-1 receptor reduces pain-related behaviors and inflammation in CFA-induced knee arthritis

Neuroscience Letters

Volumn 584, Issue , 2015, Pages 39-44

  Alvarado Vazquez, P A ^a   Morado Urbina, C E ^a   Castaneda Corral G ^b   Acosta Gonzalez, R I ^a   Kitaura, H ^c   Kimura, K ^c   Takano Yamamoto, T ^c   Jimenez Andrade J M ^a  

^a Facultad de Medicina Veterinaria y Zootecnia   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Arthritic pain; C Fms; Intra articular injection; Knee inflammation

Indexed keywords

COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR 1 RECEPTOR; COLONY STIMULATING FACTOR 1 RECEPTOR ANTIBODY; CYTOKINE ANTIBODY; FREUND ADJUVANT; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; COLONY STIMULATING FACTOR RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRALGIA; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISABILITY; EDEMA; EXPLORATORY BEHAVIOR; HEALTH STATUS; INFLAMMATION; KNEE ARTHRITIS; LEUKOCYTE; LEUKOCYTE COUNT; LONG TERM CARE; MALE; MOUSE; NONHUMAN; REARING; ANIMAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRAARTICULAR DRUG ADMINISTRATION; KNEE; PAIN; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; EDEMA; FREUND'S ADJUVANT; INFLAMMATION; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MALE; MICE, INBRED ICR; PAIN; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR;

EID: 84908632261     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.09.053     Document Type: Article

References (23)

1. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
2. Scott D.L., Wolfe F., Huizinga T.W. Rheumatoid arthritis. Lancet 2010, 376:1094-1108.
3. Tragulpiankit P., Chulavatnatol S., Rerkpattanapipat T., Janwityanujit S., Somjarit S., Sirikhedgon U. Adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients. Int. J. Rheum. Dis. 2012, 15:315-321.
4. Choy E.H., Smith C., Dore C.J., Scott D.L. A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal. Rheumatology (Oxford) 2005, 44:1414-1421.
5. Nagae M., Hiraga T., Wakabayashi H., Wang L., Iwata K., Yoneda T. Osteoclasts play a part in pain due to the inflammation adjacent to bone. Bone 2006, 39:1107-1115.
6. Toh M.L., Bonnefoy J.Y., Accart N., Cochin S., Pohle S., Haegel H., De Meyer M., Zemmour C., Preville X., Guillen C., Thioudellet C., Ancian P., Lux A., Sehnert B., Nimmerjahn F., Voll R.E., Schett G. A CSF-1 receptor monoclonal antibody has potent bone and cartilage protective effects in experimental arthritis. Arthritis Rheum. 2014.
7. Firestein G.S., Xu W.D., Townsend K., Broide D., Alvaro-Gracia J., Glasebrook A., Zvaifler N.J. Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J. Exp. Med. 1988, 168:1573-1586.
8. Campbell I.K., Rich M.J., Bischof R.J., Hamilton J.A. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J. Leukoc. Biol. 2000, 68:144-150.
9. Yang Y.H., Hamilton J.A. Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor. Arthritis Rheum. 2001, 44:111-119.
10. Hamilton J.A., Achuthan A. Colony stimulating factors and myeloid cell biology in health and disease. Trends Immunol. 2013, 34:81-89.
11. Evans C.H., Kraus V.B., Setton L.A. Progress in intra-articular therapy. Nat. Rev. Rheumatol. 2014, 10:11-22.
12. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.
13. Sudo T., Nishikawa S., Ogawa M., Kataoka H., Ohno N., Izawa A., Hayashi S., Nishikawa S. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene 1995, 11:2469-2476.
14. Kimura K., Kitaura H., Fujii T., Hakami Z.W., Takano-Yamamoto T. Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo. FEMS Immunol. Med. Microbiol. 2012, 64:219-227.
15. Gauldie S.D., McQueen D.S., Clarke C.J., Chessell I.P. A robust model of adjuvant-induced chronic unilateral arthritis in two mouse strains. J. Neurosci. Methods 2004, 139:281-291.
16. Torres-Guzman A.M., Morado-Urbina C.E., Alvarado-Vazquez P.A., Acosta-Gonzalez R.I., Chavez-Pina A.E., Montiel-Ruiz R.M., Jimenez-Andrade J.M. Chronic oral or intraarticular administration of docosahexaenoic acid reduces nociception and knee edema and improves functional outcomes in a mouse model of complete Freund's adjuvant-induced knee arthritis. Arthritis Res. Ther. 2014, 16:R64.
17. Morado-Urbina C.E., Alvarado-Vazquez P.A., Montiel-Ruiz R.M., Acosta-Gonzalez R.I., Castaneda-Corral G., Jimenez-Andrade J.M. Early, middle, or late administration of zoledronate alleviates spontaneous nociceptive behavior and restores functional outcomes in a mouse model of CFA-induced arthritis. Drug Dev. Res. 2014.
18. Lenzo J.C., Turner A.L., Cook A.D., Vlahos R., Anderson G.P., Reynolds E.C., Hamilton J.A. Control of macrophage lineage populations by CSF-1 receptor and GM-CSF in homeostasis and inflammation. Immunol. Cell Biol. 2012, 90:429-440.
19. El-Gamal M.I., Anbar H.S., Yoo K.H., Oh C.H. FMS kinase inhibitors: current status and future prospects. Med. Res. Rev. 2013, 33:599-636.
20. Shemesh S., Heller S., Salai M., Velkes S. Septic arthritis of the knee following intraarticular injections in elderly patients: report of six patients. Isr. Med. Assoc. J. 2011, 13:757-760.
21. Paniagua R.T., Chang A., Mariano M.M., Stein E.A., Wang Q., Lindstrom T.M., Sharpe O., Roscow C., Ho P.P., Lee D.M., Robinson W.H. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis. Arthritis Res. Ther. 2010, 12:R32.
22. Dieppe P.A., Lohmander L.S. Pathogenesis and management of pain in osteoarthritis. Lancet 2005, 365:965-973.
23. Takasugi K., Yamamura M., Iwahashi M., Otsuka F., Yamana J., Sunahori K., Kawashima M., Yamada M., Makino H. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis. Arthritis Res. Ther. 2006, 8:R126.